Equities

Senti Biosciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SNTI:NAQ

Senti Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.8583
  • Today's Change0.026 / 3.16%
  • Shares traded4.27k
  • 1 Year change-80.31%
  • Beta2.1474
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income(53)(71)(58)
Depreciation/depletion3.843.561.40
Non-Cash items3.51108.01
Cash taxes paid, supplemental------
Cash interest paid, supplemental------
Changes in working capital4.044.6714
Total cash from operations(41)(52)(35)
INVESTING
Capital expenditures(0.03)(12)(41)
Other investing and cash flow items, total0.0642(41)
Total cash from investing0.0330(82)
FINANCING
Financing cash flow items4.670117
Total cash dividends paid------
Issuance (retirement) of stock, net490.891.40
Issuance (retirement) of debt, net0(0.11)--
Total cash from financing540.78119
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash12(22)1.70
Net cash-begin balance/reserved for future use396159
Net cash-end balance/reserved for future use523961
SUPPLEMENTAL INCOME
Depreciation, supplemental3.843.561.40
Cash interest paid, supplemental------
Cash taxes paid, supplemental------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.